In this article
When a peptide arrives at your bench, the supplier attaches a purity figure. For a lot of researchers it's just a number on a certificate. But what that figure represents, and what's hiding in the remaining percentage, directly shapes whether your data holds up across experiments.
What purity percentage actually means

A peptide's purity is measured by HPLC, which stands for high-performance liquid chromatography. Picture the technique like a race through a long tube: your peptide and everything mixed with it are pushed through at high pressure. Different molecules travel at different speeds, and a detector at the end measures how much of each passes through. The result is a graph with peaks, and your peptide's peak gets compared to all the others.
A 98% purity figure means your peptide accounts for 98% of the area under that graph. The remaining 2% is everything else: fragments of the peptide chain that didn't complete synthesis, molecules where amino acids (the chemical building blocks of peptides) linked incorrectly, residual solvents from manufacturing, or structural variants called epimers. Epimers are mirror-image versions of the intended molecule, almost identical in structure but capable of behaving differently.
Two percent sounds minor. It compounds quickly in practice.
Why impurities distort your results
The percentage you're not measuring can behave in ways the target peptide doesn't. Some impurities are biologically inactive in your assay (a controlled test), meaning they do nothing useful. That dilutes your effective amount, so the concentration you calculated isn't the concentration actually doing work. Other impurities can be active at the same binding sites as your peptide but push in a different direction, blunting or amplifying the signal you're trying to measure.
Here's the core problem. Run an experiment with a batch at 95% purity, then repeat it with a different batch at 96% purity, and the impurity profiles are different. The inactive fraction differs. The active contaminants differ. Your result shifts not because your method changed, but because the actual compound changed between runs.
Reproducibility, getting the same result when you repeat an experiment, is the foundation of valid research. Impure, inconsistent peptide supply undermines it at the source. For receptor-binding studies or dose-response curves (experiments that measure how a compound behaves across a range of concentrations), the numbers matter more. At 95% purity, 5% of your sample is unknown variables. Run that across several experiments with different batches, and your data is chasing a moving target.
Reading a certificate of analysis
Every reputable supplier ships a certificate of analysis, usually called a CoA, with each batch. The CoA documents what the company actually measured, not what they aimed for. Check for these specifics:
- HPLC purity: Should be 98% or above for research-grade peptide. Values below this warrant questions about sourcing and manufacturing quality control.
- Mass spectrometry (MS) confirmation: HPLC measures how much is present; mass spectrometry confirms the molecule is what the label says. It works by measuring the compound's molecular weight and comparing it to the theoretical weight of the peptide sequence. A valid CoA includes both tests.
- Batch number: Every CoA should be batch-specific. A generic certificate that applies to all units of a product line tells you nothing about the vial in your hand.
- Test date: Peptides degrade over time, even as lyophilized powder (freeze-dried solid). A CoA dated two years ago is not a current measure of what's inside.
If a supplier can't provide a batch-specific CoA with both HPLC and mass spectrometry data, treat the purity claim as unverified.
What this means at the bench

Purity affects more than assay results. It shapes every calculation you make after reconstitution (dissolving the dry powder into a liquid, usually bacteriostatic water).
When you reconstitute from a vial labeled 5 mg at 95% purity, the effective amount of target peptide is 4.75 mg. At 98% purity, it's 4.9 mg. That 0.15 mg difference can push your working concentration outside your intended range, particularly at small volumes. If you then prepare serial dilutions (a series of progressively more diluted samples) for a dose-response curve, an error at the starting concentration carries through every step.
Storage choices affect purity after the vial is opened. Heat and aqueous (water-based) environments accelerate the same degradation processes that produce impurities during manufacturing in the first place. Keeping reconstituted peptide refrigerated and limiting freeze-thaw cycles, meaning the number of times you freeze and re-thaw the same sample, preserves what purity you started with.
Start with the highest purity you can source and verify it batch by batch. Everything downstream depends on that number being real.
Related from our lab: the pen · cartridges · bacteriostatic water · reconstitution calculators
Shared by PreppinPeppers for research, educational, and demonstration awareness only. We link to third-party coverage; we do not endorse it, and nothing here is medical advice or a recommendation to use any substance in humans or animals. Our products are sold for laboratory research use only.
Frequently asked questions
What does HPLC purity percentage actually mean for a peptide?
It is the area percentage of the target peptide's chromatography peak relative to all detected peaks. A 98% figure means 2% of the detected material consists of fragments, mis-linked amino acids, residual solvents, or epimers.
How does batch-to-batch purity variation affect experimental reproducibility?
Even similar purity figures can represent completely different impurity profiles. Active or inactive contaminants vary between batches, shifting assay signals independently of your method and making true cross-run reproducibility impossible to confirm.
What should a peptide certificate of analysis include to be trustworthy?
A valid CoA must show batch-specific HPLC purity (≥98% for research grade), mass spectrometry confirmation of molecular identity, a unique batch number, and a recent test date. Generic or undated certificates cannot verify vial contents.
What the research community gets wrong about peptide purity and impurities
- Treating one purity number as the whole story. Two vials both marked 98% can hold very different sets of impurities. The percentage tells you how much is target peptide, not what the leftover fraction actually is.
- Assuming the leftover percent is inert filler. Part of that fraction can be active at the same binding sites as the target peptide, so it can shift an assay signal rather than just dilute it.
- Thinking the CoA number still describes the vial on your bench. Purity is measured at the factory on a test date. After reconstitution, shaking, warming, and repeated freeze-thaw can add aggregates and fragments that were never in that original figure.
- Trusting a generic certificate. Only a batch-specific CoA that pairs HPLC purity with mass spectrometry identity ties the number to the exact vial you are holding.
- Believing more purity always matters the same amount. The level you need depends on the work. A quick screen tolerates more variability than a binding study or a dose-response curve, where small batch differences carry through every dilution step.
From our bench: If you have run the same peptide from two different batches side by side in one assay, tell us the HPLC purity printed on each certificate of analysis and how much your readout moved between them. Real observations from your own runs help other researchers see how batch-to-batch purity differences actually show up at the bench.
Sources
- Bacteriostatic Water for Injection, USP , FDA/DailyMed label (0.9% benzyl alcohol)
- Duerkop et al., Biotechnol J 2018 , Impact of Cavitation, High Shear Stress and Air/Liquid Interfaces on Protein Aggregation
- Sigma-Aldrich (Merck) , Handling and Storage Guidelines for Peptides and Proteins
- GenScript, Recommended Peptide Purity Levels & Applications (HPLC purity and deletion-sequence impurities)
✔ Reviewed by Bryan Le, PharmD, RPh
Bryan is a licensed pharmacist (Doctor of Pharmacy, Registered Pharmacist). Reconstituting lyophilized preparations is core pharmacy practice, so he reviews The Lab’s content for technical accuracy and to keep it within a research-and-education scope, with no medical or dosing advice. View profile on LinkedIn.